SAMD10

Chr 20

sterile alpha motif domain containing 10

Also known as: C20orf136, dJ591C20, dJ591C20.7

The SAMD10 protein is predicted to function in cell surface receptor protein tyrosine kinase signaling pathways at the cytoplasmic side of the plasma membrane. This gene is not well-established as a cause of human disease, with very limited clinical data available. The gene shows tolerance to loss-of-function variants in the general population.

ResearchSummary from RefSeq
DNmechanismLOEUF 1.29
Clinical SummarySAMD10
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.29LOEUF
pLI 0.001
Z-score 0.97
OE 0.65 (0.361.29)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.79Z-score
OE missense 0.80 (0.670.94)
95 obs / 119.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.65 (0.361.29)
00.351.4
Missense OE0.80 (0.670.94)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 6 / 9.2Missense obs/exp: 95 / 119.3Syn Z: -0.28
DN
0.6453th %ile
GOF
0.6248th %ile
LOF
0.4429th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SAMD10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →